Quarterly Results: Pfizer Ltd

Technical View: 

Pfizer Ltd., is currently trading at Rs. 1773.2, up by 9.1 points or 0.52% from its earlier closing of Rs. 1764.1 on the BSE.

The scrip has touched a high and low of Rs. 1830 and Rs. 1755 respectively , after opening at 1788. In totality 9273 (NSE+BSE) shares were traded on the counter; and the stock is currently trading above its 50 DMA.

Standalone Results Q2FY17: (Rs. in crore)


***EBITDA margin change in bps

Bloomberg estimate were beaten by Pfizer Ltd’s Q2FY17 standalone results . Revenue has come in higher than estimate of Rs 533 cr. Net profit is 55.8% greater than the estimated figure of Rs 81 cr yoy.

Revenue for the quarter has jumped 5.1% yoy to Rs 557.66 cr. 

Pfizer's EBITDA has dropped by 21% yoy to Rs 91 cr and EBITDA margins have sharply declined by 540 bps yoy to 16.4%. Company has witnessed this sharp fall in margins owing to price reduction announced by government. Also 28% & 17.4% yoy increase in purchase of stock in trade and Employee benefit expenses respectively added on to the drop in EBITDA margins.  

Company's net profit has surged 52.5% yoy to Rs 126.33 cr majorly supported by 47% yoy increase in other income and 946% improvement in exceptional items.